Dare Bioscience, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
Dare Bioscience, Inc. (DARE) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 70 shares for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2019-11-12
- Dare Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2019-09-30 was 0.00 shares.
- Dare Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2019-06-30 was 0.00 shares.
- Dare Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2019-03-31 was 70.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month |
|---|---|---|---|
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | 0.00 shares derived: sum of 2 quarters · filed 2019-11-12 | 70.00 shares 10-Q · filed 2019-11-12 |
| 2019-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | 70.00 shares 10-Q · filed 2019-08-14 | |
| 2019-03-31 | 70.00 shares 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |